Table 1.
Clinical characterization of people in acute (RV254, AHI) or chronic (RV304B, CHI) HIV infection and people without HIV (RV304A, HIV−) (n = 68).
| Study Cohorts | HIV infection status | Number of participants | Median age (years) | Median CD4+ T cells (cells/cu.mm.) | Median plasma HIV-RNA (copies/ml) |
|---|---|---|---|---|---|
| RV304A | HIV- | 16 | 31 (19–40) | – | – |
| RV254 | AHI Stage1 (S1) | 11 | 26 (20–54) | 654 (307-1302) | 8,970 (789-68,393) |
| RV254 | AHI Stage2 (S2) | 12 | 25 (18–44) | 290 (158–773) | 848,856 (133,705–17,867,500) |
| RV254 | AHI Stage3 (S3) | 13 | 24 (21–60) | 278 (170–794) | 1,456,069 (24,663–31,650,200) |
| RV254 | AHI Stage4/5 (S4/5) | 8 | 30 (20–40) | 477 (233–625) | 684,789 (100,793–6,936,786) |
| RV304B | CHI | 8 | 26 (20–35) | 338 (149–616) | 45,485 (12,200–621,473) |